McGuire Investment Group’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,760
Closed -$107K 122
2023
Q1
$107K Sell
14,760
-1,951
-12% -$17.3K 0.02% 113
2022
Q4
$148K Sell
16,711
-1,701
-9% -$18.7K 0.03% 110
2022
Q3
$225K Sell
18,412
-1,146
-6% -$17.9K 0.05% 103
2022
Q2
$231K Buy
19,558
+810
+4% +$10.9K 0.05% 104
2022
Q1
$357K Buy
18,748
+955
+5% +$17.8K 0.07% 89
2021
Q4
$472K Sell
17,793
-9,058
-34% -$312K 0.08% 84
2021
Q3
$1.1M Sell
26,851
-625
-2% -$34.2K 0.21% 56
2021
Q2
$1.56M Sell
27,476
-762
-3% -$28.1K 0.3% 49
2021
Q1
$1.19M Buy
28,238
+16,848
+148% +$960K 0.25% 51
2020
Q4
$799K Buy
11,390
+852
+8% +$35K 0.2% 57
2020
Q3
$296K Sell
10,538
-133
-1% -$4.33K 0.09% 80
2020
Q2
$316K Buy
+10,671
New +$279K 0.11% 73

Other funds holding EDIT

McGuire Investment Group's EDIT Position: Q2 2023 in Review

McGuire Investment Group sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 14,760 shares — an estimated $107K sold.

McGuire Investment Group first reported a position in EDIT in Q2 2020 and held it in 12 quarters. The position peaked at $1.56M in Q2 2021. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • McGuire Investment Group reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • McGuire Investment Group sold 14,760 Editas Medicine shares in Q2 2023, an estimated $107K.
  • McGuire Investment Group first reported a position in Editas Medicine in Q2 2020 and held it in 12 quarters.
  • McGuire Investment Group's Editas Medicine position peaked at $1.56M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on McGuire Investment Group's 13F filing for Q2 2023, filed 18 Jul 2023.